XML 59 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Summary of Significant Accounting Policies - Additional Information (Detail)
3 Months Ended 12 Months Ended
Jan. 01, 2019
USD ($)
lease_arrangement
Dec. 31, 2019
USD ($)
Item
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Item
Sep. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2019
USD ($)
Segment
Item
Dec. 31, 2018
USD ($)
Item
Dec. 31, 2017
USD ($)
Product Information [Line Items]                        
Number of operating segments | Segment                   1    
Total revenue   $ 3,069,000 $ 1,677,000 $ 1,804,000 $ 1,785,000 $ 1,792,000 $ 2,466,000 $ 3,931,000 $ 2,311,000 $ 8,335,000 $ 10,500,000 $ 4,666,000
Outstanding receivable   $ 2,825,000       $ 1,786,000       $ 2,825,000 $ 1,786,000  
Number of financial institutions in which cash was deposited | Item   1       1       1 1  
Aggregate amount of transaction price allocated to remaining performance obligations for contracts with original duration greater than one year   $ 200,000       $ 3,700,000       $ 200,000 $ 3,700,000  
Remaining performance obligation, expected timing of satisfaction                   The Company expects to recognize revenue on the remaining performance obligations over the next 2 years.    
Contract assets   0       0       $ 0 0  
Contract liabilities   200,000       600,000       200,000 $ 600,000  
Revenue recognized relating to contract liabilities                   600,000    
Costs to obtain or fulfill contract capitalized   0               $ 0    
Expected dividend yield                   0.00%    
US federal corporate tax rate                   21.00% 21.00% 35.00%
Transition tax recognized                   $ 0 $ 0  
Operating lease liabilities   3,856,000               3,856,000    
Right-of-use assets   3,360,000               3,360,000    
Co Development Partnership Agreement [Member] | CARB-X [Member]                        
Product Information [Line Items]                        
Total revenue                   $ 900,000 $ 1,100,000  
Accounting Standards Update 2016-02 [Member]                        
Product Information [Line Items]                        
Maximum short-term lease exception period                   12 months    
Number of operating lease arrangements | lease_arrangement 8                      
Number of finance lease arrangements | lease_arrangement 2                      
Operating lease liabilities $ 5,600,000                      
Right-of-use assets 4,800,000                      
Accrued rent liability $ 800,000                      
Minimum [Member]                        
Product Information [Line Items]                        
Aggregate amount of transaction price allocated to remaining performance obligations, original duration                   1 year 1 year  
Maximum [Member]                        
Product Information [Line Items]                        
Original expected period of contracts for which value of unsatisfied performance obligations not to be disclosed                   1 year 1 year  
T2 Dx [Member]                        
Product Information [Line Items]                        
Maintenance Services period (in years)                   1 year    
Additional period for Maintenance Service option (in years)                   1 year    
Constrained Revenue [Member]                        
Product Information [Line Items]                        
Aggregate amount of transaction price allocated to remaining performance obligations for contracts with original duration greater than one year           3,000,000         $ 3,000,000  
Instrument Rentals [Member]                        
Product Information [Line Items]                        
Total revenue                   $ 184,000 523,000  
Lease revenue                   200,000    
Contribution [Member]                        
Product Information [Line Items]                        
Total revenue   1,213,000 $ 444,000 $ 459,000 $ 329,000         2,445,000    
Contribution [Member] | Co Development Partnership Agreement [Member] | Biomedical Advanced Research and Development Authority [Member]                        
Product Information [Line Items]                        
Total revenue                   1,500,000    
Non-US [Member]                        
Product Information [Line Items]                        
Total revenue                   2,800,000 2,200,000 $ 900,000
Outstanding receivable   $ 1,200,000       $ 900,000       $ 1,200,000 $ 900,000  
Revenue [Member] | Geographic Concentration Risk [Member] | Non-US [Member]                        
Product Information [Line Items]                        
Total revenue (as a percent)                   34.00% 21.00% 19.00%
Revenue [Member] | Customer Concentration Risk [Member] | Customer One [Member]                        
Product Information [Line Items]                        
Total revenue (as a percent)                   19.00% 29.00% 19.00%
Revenue [Member] | Customer Concentration Risk [Member] | Customer Two [Member]                        
Product Information [Line Items]                        
Total revenue (as a percent)                   11.00% 15.00% 10.00%
Revenue [Member] | Customer Concentration Risk [Member] | Customer Three [Member]                        
Product Information [Line Items]                        
Total revenue (as a percent)                   8.00% 10.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer One [Member]                        
Product Information [Line Items]                        
Total revenue (as a percent)                   27.00% 25.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer Two [Member]                        
Product Information [Line Items]                        
Total revenue (as a percent)                   10.00% 22.00%